Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...

Hims & Hers Health is a top growth stock with strong cash flow, no debt, and an innovative AI-powered platform. Learn more on ...

We recently published a list of 10 Stocks Lead Friday’s Charge. In this article, we are going to take a look at where Hims & ...

Hims & Hers Health would discontinue Apostrophe, its personalized acne treatments dermatology business, the company said on ...

What Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 8% in the afternoon session after the U.S.

Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company ...

the daily return of Hims & Hers, a company pion Define Ventures, one of the largest venture capital firms focused on early-stage health tech companies, today announced that Carolyn Magill ...

Hims & Hers is shutting down the dermatology business it acquired four years ago, Business Insider has learned. On Friday, the telehealth company discontinued Apostrophe, the direct-to-consumer ...

Hims & Hers (HIMS) went all-in on weight-loss drugs. It bet big on cheaper, compounded versions of blockbuster GLP-1 treatments like ...

Online health and wellness company Hims & Hers reported fourth-quarter earnings that beat Wall Street analysts' expectations and gave upbeat guidance for 2025. But shares of the company dropped 19 ...

Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range ...

AlphaQuest LLC cut its holdings in shares of Hims & Hers Health, Inc. (NYSE:HIMS – Free Report) by 11.2% during the 4th ...